Faruqi and Faruqui, LLP Logo
Share this page

Amyris, Inc. (AMRS)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Amyris, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS).

The investigation focuses on whether the Company and its executives violated federal securities laws with respect to its disclosures concerning business, operational, and compliance policies.  Specifically, the investigation focuses on whether Amyris made false and misleading statements to the investing public regarding its ability to produce Biofene, a renewable chemical. 

On February 9, 2012, the Company disclosed that there would be a decrease in Biofene production and that it needed to raise funds.  Following this news, Amyris’ stock dropped $2.74, or over 28%.

Take Action

If you invested in Amyris’ stock or options between April 29, 2011 and February 8, 2012 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Amyris’ conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 06/28/2013

Class Period:

  • 04/29/2011 - 02/08/2012

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.